Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PODD Insulet Corporation daily Stock Chart
PODD [NASD]
Insulet Corporation
Healthcare | Medical Instruments & Supplies | USA
statements
Index- P/E758.11 EPS (ttm)0.25 Insider Own0.20% Shs Outstand60.40M Perf Week0.57%
Market Cap11.63B Forward P/E261.63 EPS next Y0.74 Insider Trans-22.66% Shs Float60.40M Perf Month12.67%
Income16.50M PEG- EPS next Q0.11 Inst Own98.50% Short Float7.27% Perf Quarter31.45%
Sales693.70M P/S16.77 EPS this Y111.80% Inst Trans-1.80% Short Ratio6.22 Perf Half Y56.12%
Book/sh2.48 P/B77.65 EPS next Y239.17% ROA1.60% Target Price177.21 Perf Year150.53%
Cash/sh9.98 P/C19.29 EPS next 5Y- ROE7.90% 52W Range73.90 - 193.39 Perf YTD12.48%
Dividend- P/FCF- EPS past 5Y15.60% ROI3.20% 52W High-0.43% Beta0.78
Dividend %- Quick Ratio6.20 Sales past 5Y17.90% Gross Margin65.80% 52W Low160.57% ATR4.19
Employees1169 Current Ratio7.00 Sales Q/Q27.10% Oper. Margin6.00% RSI (14)70.26 Volatility2.06% 2.46%
OptionableYes Debt/Eq6.55 EPS Q/Q-49.60% Profit Margin2.40% Rel Volume0.43 Prev Close192.00
ShortableYes LT Debt/Eq6.55 EarningsFeb 25 AMC Payout0.00% Avg Volume705.71K Price192.56
Recom2.20 SMA206.90% SMA507.41% SMA20036.13% Volume301,002 Change0.29%
Dec-10-19Initiated CFRA Sell $163
Oct-23-19Initiated Stifel Hold
Oct-18-19Downgrade Canaccord Genuity Buy → Hold $135 → $145
Oct-14-19Downgrade BTIG Research Buy → Neutral
Oct-04-19Downgrade UBS Buy → Neutral $155 → $160
Oct-03-19Downgrade Guggenheim Buy → Neutral
Aug-06-19Upgrade JP Morgan Neutral → Overweight $120 → $155
Jun-10-19Downgrade Northland Capital Outperform → Market Perform
May-06-19Upgrade BTIG Research Neutral → Buy $115
Apr-20-18Initiated Berenberg Buy $100
Feb-22-18Reiterated Barclays Overweight $85 → $90
Jan-08-18Upgrade Raymond James Mkt Perform → Outperform
Nov-03-17Upgrade Canaccord Genuity Hold → Buy $50 → $65
Sep-15-17Initiated Barclays Overweight $65
Jul-17-17Downgrade BTIG Research Buy → Neutral
May-25-17Resumed William Blair Outperform
May-22-17Resumed Piper Jaffray Overweight
Feb-28-17Reiterated Wedbush Outperform $48 → $50
Jan-06-17Upgrade Robert W. Baird Neutral → Outperform $39 → $47
Aug-04-16Reiterated Wedbush Outperform $44 → $48
Jan-17-20 08:27AM  Diabetes Management Gains FDA Attention: 3 Stocks in Focus Zacks
Jan-14-20 10:52AM  Insulet Nears Breakout Investor's Business Daily Video
Jan-11-20 08:00AM  These Four Stocks Are In Buy Range Before Key Healthcare Conference Investor's Business Daily
Jan-07-20 02:54PM  Insulet Corporation (PODD) vs. Top 20 Hedge Fund Stocks in 2019 Insider Monkey
08:09AM  Dow Jones Futures: Key Sector Rejoins Stock Market Rally; These 6 Stocks Just Entered Buy Zones Investor's Business Daily
Jan-06-20 03:11PM  These Are The 5 Best Stocks To Buy And Watch Now Investor's Business Daily
08:00AM  Dow Jones Futures: Can Stock Market Rally Hold In Bullish Channel As Iran Exits Nuclear Deal? 7 Stocks Near Buy Points Investor's Business Daily
07:00AM  Insulet to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020 Business Wire
Jan-02-20 08:10AM  Dow Jones Futures Signal Gains To Start 2020: Tesla Deliveries Loom; Google, Disney Test Key Support Investor's Business Daily
Dec-31-19 10:53AM  Here's Why You Should Hold on to Insulet (PODD) Stock Now Zacks
Dec-20-19 07:00AM  Insulet to Present at 38th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-18-19 01:00AM  First Patients in Europe Start Using Insulets New Omnipod DASH Insulin Management System in the UK and the Netherlands Business Wire
Dec-17-19 10:04AM  Insulet Rides on Innovation, Omnipod's Wider Market Appeal Zacks
09:00AM  How Good Is Insulet Corporation (NASDAQ:PODD), When It Comes To ROE? Simply Wall St.
Dec-05-19 11:31AM  Why Is Insulet (PODD) Up 14.3% Since Last Earnings Report? Zacks
Dec-04-19 10:43AM  5 Companies Achieve 52-Week Highs GuruFocus.com
Dec-03-19 01:56PM  Hedge Funds Have Never Been This Bullish On Insulet Corporation (PODD) Insider Monkey
Nov-28-19 08:14AM  Digital Diabetes Management Gains Momentum: 3 Stocks in Focus Zacks
Nov-15-19 09:21AM  Insulet (PODD) Hits a 52-Week High: What's Driving the Stock? Zacks
Nov-13-19 09:46AM  Insulet Rides on Omnipod's Wider Market Reach, New Products Zacks
Nov-11-19 11:04PM  Edited Transcript of PODD earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-07-19 08:53AM  Insulet (PODD) Beats on Q3 Earnings, Ups '19 Revenue View Zacks
07:00AM  Insulet to Present at Upcoming Investor Conferences Business Wire
Nov-06-19 04:35PM  This IBD Stock Of The Day Just Bounded Above An Aggressive Buy Point Investor's Business Daily +10.48%
07:57AM  Dow Jones Futures: Xerox-HP Deal Mulled; Match Group Dives; Roku, Carvana Earnings Due Investor's Business Daily
06:28AM  Dow Jones Futures: 5 Big Earnings Movers After Stock Market Rally Pauses Investor's Business Daily
Nov-05-19 05:15PM  Insulet (PODD) Surpasses Q3 Earnings and Revenue Estimates Zacks
04:01PM  Insulet Reports Third Quarter 2019 Revenue of $192 Million, an Increase of 27% Year-Over-Year Business Wire
Nov-04-19 11:15AM  Medical Products' Earnings Roster for Nov 5: BDX, ZBH & More Zacks
09:37AM  3 Medical Product Stocks Likely to Beat This Earnings Season Zacks
08:33AM  Why Earnings Season Could Be Great for Insulet (PODD) Zacks
Oct-30-19 09:15AM  Small Step Back Ahead of Fed, Apple Zacks
Oct-29-19 10:33AM  Insulet (PODD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Oct-25-19 06:00AM  Fiasp® Rapid Acting Insulin for Adults Now Approved for Use With the Omnipod Insulin Management System Platform in the United States Business Wire
Oct-18-19 10:18AM  These 4 Measures Indicate That Insulet (NASDAQ:PODD) Is Using Debt Reasonably Well Simply Wall St.
07:35AM  Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? Zacks
Oct-15-19 11:05AM  Hedge Funds Have Never Been More Bullish On Insulet Corporation (PODD) Insider Monkey
Oct-02-19 09:15AM  Rough Start to Fourth Quarter Zacks
Sep-30-19 07:00AM  Insulet to Announce Third Quarter 2019 Financial Results on November 5, 2019 Business Wire
Sep-24-19 09:20AM  Insulet Receives FDA Approval for ACE Pump Implementation Zacks
Sep-23-19 11:00AM  Insulet's Insulin Delivery System Receives FDA Clearance As ACE Pump For Drug Infusion Benzinga
06:00AM  Insulets Omnipod DASH System Now FDA Cleared as an Alternate Controller Enabled (ACE) Infusion Pump Business Wire
Sep-04-19 09:30AM  Why Is Insulet (PODD) Up 17.3% Since Last Earnings Report? Zacks -6.45%
09:24AM  Insulet (PODD) Scales 52-Week High: What's Driving the Stock? Zacks
08:40AM  Insulet (PODD) Catches Eye: Stock Jumps 8.9% Zacks
08:30AM  Why Diabetes Stock Insulet Soared 25% in August Motley Fool
07:50AM  Dow Jones Futures Signal Solid Stock Market Rally On Hong Kong News; Coupa Software Set To Break Out Investor's Business Daily
07:08AM  The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books Benzinga
06:00AM  Insulet Announces Pricing of Convertible Senior Notes Due 2026 Business Wire
Sep-03-19 06:29PM  Dow Jones Futures: Stock Market Still Rangebound; Coupa Software, Tyson, Okta, Insulet Active Late Investor's Business Daily +8.94%
12:23PM  Why Insulet Corporations (NASDAQ:PODD) Return On Capital Employed Looks Uninspiring Simply Wall St.
Aug-15-19 05:09PM  Edited Transcript of PODD earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
05:07PM  Edited Transcript of PODD earnings conference call or presentation 21-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
01:38PM  Edited Transcript of PODD earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-14-19 09:35AM  Here's Why You Should Hold Onto Insulet (PODD) Stock for Now Zacks
Aug-13-19 07:01AM  Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? Zacks
06:00AM  How one Boston startup rode the diabetes investment wave to raise $126M American City Business Journals
Aug-09-19 10:05AM  Insulet Omnipod DASH System Mobile Apps Now Available for iOS Devices Business Wire
Aug-07-19 08:15AM  Insulet's Revenue Surges; Stock Soars 21% Motley Fool
Aug-06-19 03:09PM  Why Insulet's Shares Are Rocketing 20.8% Higher Today Motley Fool +21.37%
11:54AM  Insulet (PODD) Misses on Q2 Earnings, Ups '19 Revenue View Zacks
05:43AM  Edited Transcript of PODD earnings conference call or presentation 5-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-05-19 09:23PM  Insulet Corp (PODD) Q2 2019 Earnings Call Transcript Motley Fool
05:25PM  Insulet (PODD) Q2 Earnings Lag Estimates Zacks
04:01PM  Insulet Reports Second Quarter 2019 Revenue of $177 Million, an Increase of 43% Year-Over-Year Business Wire
02:30PM  Insulet Corp. to Host Earnings Call ACCESSWIRE
Jul-31-19 04:01PM  Insulet Appoints Jim Hollingshead to Board of Directors Business Wire
Jul-29-19 10:34AM  Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Jul-24-19 04:01PM  Insulet to Present at Upcoming Investor Conferences Business Wire
Jul-19-19 01:08PM  The Insulet (NASDAQ:PODD) Share Price Is Up 252% And Shareholders Are Boasting About It Simply Wall St.
Jul-17-19 04:01PM  Insulet to Debut New Educational Self-Advocacy Tool at 20th Annual Children with Diabetes Friends for Life Conference Business Wire
Jul-15-19 10:00AM  3 Top Diabetes Stocks to Watch in July Motley Fool
09:15AM  Insulet (PODD) Soars to 52-Week High, Time to Cash Out? Zacks
Jul-02-19 06:00AM  Haemonetics and Insulet- Growth Expert Eyes Medical Devices MoneyShow
Jun-26-19 04:01PM  Insulet to Announce Second Quarter 2019 Financial Results on August 5, 2019 Business Wire
Jun-25-19 10:49AM  Inside the low-key Boston design firm behind everything from sneakers to 'body on a chip' American City Business Journals
Jun-14-19 04:39PM  Did Hedge Funds Drop The Ball On Insulet Corporation (PODD) ? Insider Monkey
Jun-13-19 07:59AM  Insulet (PODD) Hits 52-Week High on Solid Growth Prospects Zacks
Jun-09-19 09:30PM  Insulets Omnipod® Horizon Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 Diabetes Business Wire
Jun-06-19 06:00AM  Insulet to Showcase its Recently-Launched Omnipod® DASH System and Present Seven Scientific Abstracts at the American Diabetes Association's 79th Scientific Sessions Business Wire
Jun-04-19 07:18AM  Why Diabetes Stock Insulet Soared 27.3% in May Motley Fool
Jun-01-19 09:31AM  Insulet (PODD) Up 27.8% Since Last Earnings Report: Can It Continue? Zacks
May-30-19 04:11PM  How IBD Called The Stock Market Correction Quickly And Where It May Go From Here Investor's Business Daily
May-29-19 04:01PM  Edited Transcript of PODD earnings conference call or presentation 2-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-16-19 06:00AM  Insulet to Present at Upcoming Investor Conferences Business Wire
May-15-19 12:28PM  Insulet and West Pharma Proven Winners in Growing Wearable Devices Market GuruFocus.com
May-13-19 03:00AM  Insulet and Novocure Are Going Gangbusters Motley Fool
May-10-19 12:02PM  2 Winners and 2 Losers in the Med Tech Market This Quarter Motley Fool
May-04-19 03:00PM  Insulet Kicks Off 2019 With a Strong Quarter; Stock Soars 12% Motley Fool
May-03-19 12:11PM  Why Diabetes-Disruptor Insulet Is Skyrocketing 10% Today Motley Fool +12.30%
10:15AM  Should You Be Worried About Insulet Corporation's (NASDAQ:PODD) 1.6% Return On Equity? Simply Wall St.
09:14AM  Insulet Corp (PODD) Q1 2019 Earnings Call Transcript Motley Fool
08:02AM  Insulet (PODD) Beats Earnings and Revenue Estimates in Q1 Zacks
06:52AM  Medical device maker Insulet opens new Acton headquarters American City Business Journals
May-02-19 05:45PM  Insulet (PODD) Q1 Earnings and Revenues Beat Estimates Zacks
04:37PM  Insulet: 1Q Earnings Snapshot Associated Press
04:01PM  Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year Business Wire
06:00AM  Insulet Celebrates New Global Headquarters and U.S. Manufacturing Facility in Acton, MA Business Wire
May-01-19 12:01PM  Did David Stick His Neck Out Too Far With This 5-Stock Sampler? Motley Fool
Apr-29-19 10:10AM  Why the Earnings Surprise Streak Could Continue for Insulet (PODD) Zacks
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, which consists of self-adhesive disposable tubeless Omnipod device (the pod) that delivers insulin into the body; and Personal Diabetes Manager, a handheld wireless device, which programs the Pod. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, Israel, the United Kingdom, the Netherlands, and internationally. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Petrovic ShaceyPresident and CEOJan 02Option Exercise30.5812,500382,250108,030Jan 06 05:17 PM
Petrovic ShaceyPresident and CEOJan 02Sale169.6312,5002,120,37395,530Jan 06 05:17 PM
Lemoine David ADirectorJan 02Sale171.242,884493,8567,990Jan 06 05:13 PM
Fallon John A.DirectorNov 18Option Exercise28.499,525271,37922,994Nov 19 04:08 PM
Fallon John A.DirectorNov 18Sale181.419,5251,727,91813,469Nov 19 04:08 PM
Fallon John A.DirectorNov 15Option Exercise21.355,000106,75018,469Nov 19 04:08 PM
Petrovic ShaceyPresident and CEONov 15Option Exercise29.263,41799,98197,927Nov 19 04:10 PM
Fallon John A.DirectorNov 15Sale180.075,000900,32513,469Nov 19 04:08 PM
Spears Michael PSVP, RA and ComplianceNov 14Option Exercise29.261,10032,18623,726Nov 15 04:37 PM
Petrovic ShaceyPresident and CEONov 01Sale145.69689100,38094,510Nov 01 05:29 PM
Petrovic ShaceyPresident and CEOSep 03Sale152.4064998,90895,199Sep 05 04:13 PM
Spears Michael PSVP, RA and ComplianceAug 15Sale146.124,153606,83622,626Aug 19 04:14 PM
Spears Michael PSVP, RA and ComplianceJun 13Option Exercise29.262,00058,52027,275Jun 14 04:05 PM
Petrovic ShaceyPresident and CEOJun 05Sale113.00895101,13595,559Jun 05 05:21 PM
CRAWFORD SALLYDirectorMay 31Option Exercise28.9828,347821,38656,816Jun 03 05:35 PM
CRAWFORD SALLYDirectorMay 31Sale108.6028,3473,078,48428,469Jun 03 05:35 PM
Lemoine David ADirectorMay 16Option Exercise26.008,752227,55217,900May 17 04:07 PM
Lemoine David ADirectorMay 16Sale106.928,752935,7579,148May 17 04:07 PM
Lemoine David ADirectorMay 15Sale102.4987489,5769,148May 17 04:07 PM
Alpuche CharlesEVP & Chief Operating OfficerMay 15Sale104.783,900408,65239,244May 17 04:05 PM
Colleran DavidSVP, Secretary and GCApr 02Option Exercise30.987,395229,09737,828Apr 04 04:02 PM
Colleran DavidSVP, Secretary and GCApr 02Sale94.897,395701,71230,433Apr 04 04:02 PM
Fallon John A.DirectorMar 20Option Exercise21.355,000106,75016,743Mar 22 04:16 PM
Fallon John A.DirectorMar 20Sale100.005,000500,00011,743Mar 22 04:16 PM
Fallon John A.DirectorMar 12Option Exercise21.355,000106,75016,743Mar 14 05:06 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMar 12Option Exercise37.0927,3491,014,38151,341Mar 14 05:07 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMar 12Sale94.0327,3492,571,61323,992Mar 14 05:07 PM
Fallon John A.DirectorMar 12Sale95.005,000475,00011,743Mar 14 05:06 PM
Fallon John A.DirectorMar 06Option Exercise21.3510,000213,50021,743Mar 08 04:06 PM
Petrovic ShaceyPresident and CEOMar 06Sale92.641,06698,75496,454Mar 08 04:14 PM
Fallon John A.DirectorMar 06Sale92.6410,000926,40011,743Mar 08 04:06 PM
Colleran DavidSVP, Secretary and GCMar 01Option Exercise35.5420,975745,54451,408Mar 05 07:15 PM
Abdel-Malek AimanEVP & Chief Technology OfficerMar 01Sale95.221,608153,11923,992Mar 05 07:17 PM
Colleran DavidSVP, Secretary and GCMar 01Sale94.6520,9751,985,35930,433Mar 05 07:15 PM
Lemoine David ADirectorMar 01Sale94.2956152,89610,022Mar 05 07:06 PM
Levitz Michael LSVP and CFOFeb 27Sale92.011,350124,21456,651Feb 28 08:44 PM
Colleran DavidSVP, Secretary and GCFeb 05Option Exercise29.266,834199,96340,967Feb 06 04:34 PM
Colleran DavidSVP, Secretary and GCFeb 05Sale80.726,834551,64034,133Feb 06 04:34 PM
Colleran DavidSVP, Secretary and GCJan 31Option Exercise29.264,826141,20938,959Feb 01 05:29 PM
Colleran DavidSVP, Secretary and GCJan 31Sale80.004,826386,08034,133Feb 01 05:29 PM
open in yahoo | open in reuters | open in google